NDAOTICSOLUTION/DROPS
Approved
Jun 1961
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
VOSOL HC (hydrocortisone and acetic acid otic) by Saptalis Pharms is corticosteroid hormone receptor agonists [moa]. First approved in 1961.
Drug data last refreshed 13h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VOSOL HC is a topical otic solution combining hydrocortisone (a corticosteroid) and acetic acid for treatment of ear infections and inflammatory conditions of the external auditory canal. It works by activating corticosteroid hormone receptors to reduce inflammation and suppress immune response in the ear. The acetic acid component provides antimicrobial and pH-balancing properties.
LOE Approaching
Long-established product approaching loss of exclusivity with moderate competitive pressure (30%), signaling transition from growth maintenance to lifecycle management roles.
Mechanism of Action
Corticosteroid Hormone Receptor Agonists
Pharmacologic Class:
Corticosteroid
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
VOSOL HC offers limited direct job openings (0 linked positions) but represents a stable, niche product ideal for professionals building expertise in ear, nose, and throat (ENT) pharmaceuticals and lifecycle management. Working on this product provides exposure to mature market dynamics, generic competition strategy, and cost-containment challenges rather than launch or growth innovation.
Brand Manager
Worked on VOSOL HC at Saptalis Pharms? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.